Tradestie Institutional Equity Comparison Engine

AMLX vs NTLA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

AMLX Overall Edge

AMLX Captures Institutional Edge (4โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Amylyx Pharmaceuticals, Inc. Common Stock (AMLX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, AMLX trades at 2.8x Forward P/E with 0.0% operating margin (-99.6% YoY revenue) versus NTLA at N/M Forward P/E and -826.0% operating margin (-48.0% YoY). In options structure, AMLX sits in BREAKDOWN (10th %ile IV; Dealer Gamma Walls on Pro) against NTLA sits in BREAKDOWN (78th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner AMLX
AMLX 2.8x vs NTLA N/M Fwd P/E
Growth & Margin Winner AMLX
Op Margin 0.0% vs -826.0% ยท YoY -99.6% vs -48.0%
Momentum & Technical Winner AMLX
1Y +127.3% vs +15.3% ยท 52W Pos 57% vs 20%
Options & Structure Winner AMLX
BREAKDOWN (10th %ile IV) vs BREAKDOWN (78th %ile IV)
AMLX NASDAQ
Amylyx Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$28.23
-6.78% 1D
Market Cap $3.8B
1M Return +7.19%
1Y Return +127.33%
Forward P/E 2.8x
Unified AI Score
59.8 / 100 HOLD
Tech 49.0 Fund 55.0 Flow 64.0 Mom 60.0
NTLA NASDAQ
Intellia Therapeutics, Inc
In Vitro & In Vivo Diagnostic Substances
$10.00
+3.09% 1D
Market Cap $1.5B
1M Return -12.43%
1Y Return +15.34%
Forward P/E N/M
Unified AI Score
50.7 / 100 HOLD
Tech 47.0 Fund 55.0 Flow 59.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AMLX +127.33% NTLA +15.34% Spread: +111.99 pp (AMLX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period AMLX Revenue NTLA Revenue AMLX Op. Margin NTLA Op. Margin Margin Edge
FY2018 N/A $30M N/A -298.6% NTLA
FY2019 N/A $40M N/A -246.8% NTLA
FY2020 N/A $60M N/A -235.5% NTLA
FY2021 $0M $30M -29013.3% -810.4% NTLA
FY2022 $20M $50M -905.7% -879.0% NTLA
FY2023 $380M $40M 10.2% -1420.5% AMLX
FY2024 $90M $60M -360.2% -923.1% AMLX
FY2025 N/A $70M N/A -651.7% NTLA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AMLX (8) vs NTLA (1)
Institutional Metric AMLX NTLA Criterion Row Winner
Market Capitalization Scale $3.8B $1.5B Larger Scale AMLX
Trailing P/E Ratio Valuation 2.8x N/M Lower Multiple AMLX
Forward P/E Ratio Valuation 2.8x N/M Lower Multiple AMLX
Revenue Growth (YoY) Growth -99.6% -48.0% Higher Growth NTLA
Operating Margin (TTM) Profitability 0.0% -826.0% Higher Margin AMLX
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -30.1% -62.6% Higher ROE AMLX
52-Week Range Position Momentum 57% ($11โ€“$41) 20% ($8โ€“$18) Stronger Trend AMLX
Beta / 30D Volatility Risk Regime 1.16ฮฒ ยท 59% Vol 2.30ฮฒ ยท 87% Vol Lower Realized Risk AMLX
Unified Institutional Score Composite Signal 59.8 / 100 (HOLD) 50.7 / 100 (HOLD) Higher Composite AMLX

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AMLX vs NTLA Buy Guide
AMLX BREAKDOWN
61d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live AMLX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
NTLA BREAKDOWN
94d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 78th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live NTLA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AMLX nor NTLA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.